Triple-negative breast cancer (TNBC) is defined by the absence of the estrogen receptor (ERα), progesterone receptor (PR), and the human epidermal growth factor receptor-2 (ERBB2/HER2) in tumor cells. Here, ESR1 is linked to triple-negative breast carcinoma.